LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | AZD7762 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 1961 | 4012 | 0.4890 | 0.3221 |
MCF7 | Dasatinib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 1642 | 4012 | 0.4094 | 0.1929 |
MCF7 | Crizotinib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3621 | 4203 | 0.8617 | 0.8409 |
MCF7 | HG-5-113-01 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3957 | 4203 | 0.9412 | 0.9334 |
MCF7 | AT-7519 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 1716 | 4012 | 0.4263 | 0.2189 |
MCF7 | BMS345541 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 4237 | 4012 | 1.0560 | 1.0640 |
MCF7 | NVP-TAE684 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 1984 | 4012 | 0.4944 | 0.3304 |
MCF7 | KIN001-043 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 3628 | 4012 | 0.9066 | 0.8906 |
MCF7 | Lapatinib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 3516 | 4012 | 0.8766 | 0.8534 |
MCF7 | HG-5-88-01 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 3074 | 4012 | 0.7659 | 0.7136 |
MCF7 | CP466722 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 4412 | 4203 | 1.0522 | 1.0586 |
MCF7 | YM 201636 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 4290 | 4203 | 1.0216 | 1.0245 |
MCF7 | Seliciclib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 4445 | 4203 | 1.0582 | 1.0640 |
MCF7 | AZD8055 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 1199 | 4012 | 0.2986 | -0.0063 |
MCF7 | JW-7-24-1 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 2904 | 4012 | 0.7236 | 0.6583 |
MCF7 | HG-6-64-01 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 4320 | 4012 | 1.0763 | 1.0866 |
MCF7 | Sigma A6730 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3392 | 4203 | 0.8075 | 0.7755 |
MCF7 | Saracatinib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 3381 | 4012 | 0.8425 | 0.8111 |
MCF7 | Dasatinib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3206 | 4203 | 0.7621 | 0.7182 |
MCF7 | Selumetinib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 3122 | 4012 | 0.7787 | 0.7308 |
MCF7 | CGP60474 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3388 | 4203 | 0.8081 | 0.7768 |
MCF7 | Neratinib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3690 | 4203 | 0.8761 | 0.8552 |
MCF7 | CP724714 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3813 | 4203 | 0.9088 | 0.8972 |
MCF7 | SU11274 | 0.04 | uM | LJP5 | 72 | hr | 1209 | 4485 | 4203 | 1.0671 | 1.0727 |
MCF7 | Celastrol | 0.04 | uM | LJP6 | 72 | hr | 1209 | 4182 | 4012 | 1.0446 | 1.0523 |